MacroH2A1.1 is also a target for PARP1, which in turn is a common target for cancer drug development, because of PARP-1’s involvement in many cellular activities including DNA repair and transcription factor regulation [163,164,165]. This evidence concerns the gene MACROH2A1 and cancer.